Carlyle Group portfolio companies in advanced talks for a potential merger

By

-

2 months ago

Sequent Scientific, which is in animal health business, posted revenue of around Rs 1,400 crore in FY24. It had earnings before interest, tax, depreciation and amortisation of Rs 100 crore. It has seven manufacturing sites in India, Spain, Brazil and Turkey. Viyash was founded in February 2019 by Hari Babu, formerly the chief operating officer of the world's largest generic drug maker, Mylan, now known as Viatris. Viyash posted FY24 revenue of Rs 1,400 crore with ebitda at Rs 150 crore.

Read The Rest at :

Economic Times

Topics:

sequent scientific

carlyle group

sequent scientific

viyash life sciences

Disclaimer : Mymoneytimes implements extreme caution and care in collecting data before publication. Mymoneytimes does not liable for the adequacy, accuracy or completeness of any given information. Hence we are not liable for any kind of direct or indirect loss caused by the use of such information.